March 27 (Reuters) - Novartis AG NOVN.S:
NOVARTIS AGREES TO ACQUIRE EXCELLERGY, INC., BUILDING ON ALLERGY LEADERSHIP WITH NEXT-GENERATION ANTI-IGE INNOVATION
NOVARTIS AG - TO PAY UP TO $2 BILLION TO BUY EXCELLERGY
NOVARTIS AG - NOVARTIS WILL PAY UP TO USD 2 BILLION IN UPFRONT AND MILESTONE PAYMENTS TO ACQUIRE EXCELLERGY
NOVARTIS AG - TRANSACTION IS EXPECTED TO CLOSE IN H2 2026